Mpox Preparedness and Response 2024: Position Statement of The Disaster Management Experts Club

Authors

  • Heetaf Aloqaily Department of Emergency Medicine, King Saud Hospital, Ministry of Health, Unaizah, Saudi Arabia.
  • Rania Abdurhman Alnafea Infection Control Department, King Fahd Medical City, Riyadh, Saudi Arabia
  • Shahad Abdullah Alotaibi Department of Emergency Medicine, King Saud University, Riyadh, Saudi Arabia
  • Mohamad Bakir College of Medicine, Alfaisal University
  • Sharafaldeen Bin Nafisah Clinical Research Department, The Emergency Department & Disaster Management and Emergency Dispatch Center, King Fahd Medical City, Riyadh, Saudi Arabia.
  • Bandr Mzahim The Emergency Department & Disaster Management and Emergency Dispatch Center, King Fahd Medical City, Riyadh, Saudi Arabia.

DOI:

https://doi.org/10.52609/jmlph.v5i1.163

Keywords:

Disaster Response, Infection, Mitigation, Mpox, Pandemic, Position Statement, PPE, Preparedness

Abstract

Statement of intent

The worldwide re-emergence of mpox underlines the pressing necessity for a strengthened, coordinated, international strategy to manage and avert future outbreaks. The Disaster Management Experts Club promotes an approach that emphasises strong surveillance systems, healthcare readiness, and global cooperation to avert dissemination of thisvirus. Although mpox has demonstrated a comparatively mild clinical presentation in numerous instances, especially relative to its initial outbreaks, its capacity for rapid transmission, particularly among immunocompromised individuals, necessitates a proactive global response.

The objective of this position is to reduce the current threats associated with mpox and prevent potential future pandemics. Through this, the Disaster Management Experts Club seeks to advocate:

  • Augmented surveillance and proactive detection: Surveillance systems are crucial for identifying cases, monitoring transmission dynamics, and detecting potential mutations. The need to augment early warning systems encompasses not only case identification, but also indirect indicators such as absenteeism from employment or education.
  • Enhancedresilience of healthcare systems: A resilient healthcare infrastructure that facilitates early case detection, isolation, and infection control is essential. The smooth transition of patients through primary healthcare, prehospital care, and hospital triage is vital for effectivempox Infection control measures, including the use of personal protective equipment (PPE) and rigorous environmental cleaning protocols, must be intensified to reduce nosocomial infections, as evidenced in previous outbreaks.
  • International collaboration: A proactive coalition can limit the dissemination of mpox, especially considering its zoonotic origins and cross-border transmission. Cooperative initiatives among public health organisations, government entities, and healthcare providers are essential to the establishment of a comprehensive database to monitor and analyse mpox cases across various regions.

 

Abstract

The global emergence of mpox, previously known as monkeypox, traces back to the mid-19th century. The 2022 outbreak represented a significant escalation, prompting the World Health Organization (WHO) to declare a public health emergency. The imminent risk of a pandemic requires a proactive strategy for preparedness and mitigation. Despite human-to-human transmission, the clinical manifestations of mpox in the recent outbreak were notably milder, frequently presenting as subclinical prodromes and benign skin lesions resembling those of common sexually transmitted infections. Although complications were rare, they included severe outcomes such as pneumonia, sepsis, and neurological issues, particularly in immunocompromised individuals.

Effective management of the outbreak required robust surveillance systems for early case detection, trend monitoring, and contact tracing. The smooth flow of patients through primary healthcare, prehospital care, and hospital triage was critical for early detection and isolation of suspected cases. Infection control measures, including the use of personal protective equipment (PPE) and environmental cleaning protocols, played a role in reducing nosocomial infection.

This article highlights the importance of training healthcare providers, fostering collaboration across health sectors, and developing disaster preparedness plans to respond effectively to future outbreaks. It also explores the role of individual and mass vaccination, particularly among high-risk populations. This publication serves as a comprehensive resource for understanding the mpox pandemic and the collaborative efforts of the Disaster Management Experts Club in tackling this public health challenge.

References

GOV.UK [Internet]. [cited 2024 Sep 28]. Mpox: background information. Available from: https://www.gov.uk/guidance/monkeypox

World Health Organization. Mpox [Internet]. [cited 2024 Sep 28]. Available from: https://www.who.int/news-room/fact-sheets/detail/mpox

Lu J, Xing H, Wang C, Tang M, Wu C, Ye F, Yin L, Yang Y, Tan W, Shen L. Mpox (formerly monkeypox): pathogenesis, prevention, and treatment. Signal Transduct Target Ther. 2023 Dec 27;8(1):458. doi: 10.1038/s41392-023-01675-2. PMID: 38148355; PMCID: PMC10751291.

World Health Organization. Multi-country monkeypox outbreak in non-endemic countries: Update [Internet]. [cited 2024 Sep 28]. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON388

UK Health Security Agency. Monkeypox cases confirmed in England – latest updates. Updated 2022 June 21. Accessed 2022 June 26. https://www.gov.uk/government/news/monkeypox-cases-confirmed-in-england-latest-updates

Minhaj FS, Ogale YP, Whitehill F, Schultz J, Foote M, Davidson W, Hughes CM, Wilkins K, Bachmann L, Chatelain R, Donnelly MAP, Mendoza R, Downes BL, Roskosky M, Barnes M, Gallagher GR, Basgoz N, Ruiz V, Kyaw NTT, Feldpausch A, Valderrama A, Alvarado-Ramy F, Dowell CH, Chow CC, Li Y, Quilter L, Brooks J, Daskalakis DC, McClung RP, Petersen BW, Damon I, Hutson C, McQuiston J, Rao AK, Belay E, McCollum AM; Monkeypox Response Team 2022. Monkeypox Outbreak - Nine States, May 2022. MMWR Morb Mortal Wkly Rep. 2022 Jun 10;71(23):764-769. doi: 10.15585/mmwr.mm7123e1. PMID: 35679181; PMCID: PMC9181052.

Centers for Disease Control. 2022 Mpox Outbreak Global Map | Mpox | Poxvirus | CDC. www.cdc.gov. Published 2023 September 12. https://www.cdc.gov/poxvirus/Mpox/response/2022/world-map.html#print

American Veterinary Medical Association [Internet]. Mpox (Monkeypox) [Internet]. [cited 2024 Sep 28]. Available from: https://www.avma.org/resources-tools/one-health/veterinarians-and-public-health/monkeypox

Ghazanfar A. Epidemiology, clinical Features, diagnosis and management of monkeypox virus: A clinical review article. Cureus. 2022 Aug 30;14(8):e28598. doi: 10.7759/cureus.28598. PMID: 36185896; PMCID: PMC9521816.

Koenig KL, Beÿ CK, Marty AM. Monkeypox 2022: A primer and Identify-Isolate-Inform (3I) tool for emergency medical services professionals. Prehospital and Disaster Medicine. 2022;37(5):687-692. doi:10.1017/S1049023X22001121

Koenig KL, Beÿ CK, Marty AM. Monkeypox 2022 Identify-Isolate-Inform: A 3I Tool for frontline clinicians for zoonosis with escalating human community transmission. One Health. 2022; 15:100410. doi: 10.1016/j.onehlt.2022.100410

Centers for Disease Control and Prevention. Mpox in the U.S. Published 2022 August 23. https://www.cdc.gov/poxvirus/Mpox/clinicians/clinical-recognition.html

Di Giulio DB, Eckburg PB. Human monkeypox: an emerging zoonosis [published correction appears in Lancet Infect Dis. 2004 Apr;4(4):251]. Lancet Infect Dis. 2004;4(1):15-25. doi:10.1016/s1473-3099(03)00856-9

Tarín-Vicente EJ, Alemany A, Agud-Dios M, Ubals M, Suñer C, Antón A, Arando M, Arroyo-Andrés J, Calderón-Lozano L, Casañ C, Cabrera JM, Coll P, Descalzo V, Folgueira MD, García-Pérez JN, Gil-Cruz E, González-Rodríguez B, Gutiérrez-Collar C, Hernández-Rodríguez Á, López-Roa P, de Los Ángeles Meléndez M, Montero-Menárguez J, Muñoz-Gallego I, Palencia-Pérez SI, Paredes R, Pérez-Rivilla A, Piñana M, Prat N, Ramirez A, Rivero Á, Rubio-Muñiz CA, Vall M, Acosta-Velásquez KS, Wang A, Galván-Casas C, Marks M, Ortiz-Romero PL, Mitjà O. Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study. Lancet. 2022 Aug 27;400(10353):661-669. doi: 10.1016/S0140-6736(22)01436-2. Epub 2022 Aug 8. Erratum in: Lancet. 2022 Dec 10;400(10368):2048. doi: 10.1016/S0140-6736(22)02504-1. PMID: 35952705; PMCID: PMC9533900.

Sah R, Mohanty A, Abdelaal A, Reda A, Rodriguez-Morales AJ, Henao-Martinez AF. First Monkeypox deaths outside Africa: no room for complacency. Ther Adv Infect Dis. 2022; 9:20499361221124027. Published 2022 Aug 26. doi:10.1177/20499361221124027

Sejvar JJ, Chowdary Y, Schomogyi M, Stevens J, Patel J, Karem K, Fischer M, Kuehnert MJ, Zaki SR, Paddock CD, Guarner J, Shieh WJ, Patton JL, Bernard N, Li Y, Olson VA, Kline RL, Loparev VN, Schmid DS, Beard B, Regnery RR, Damon IK. Human monkeypox infection: a family cluster in the midwestern United States. J Infect Dis. 2004 Nov 15;190(10):1833-40. doi: 10.1086/425039. Epub 2004 Oct 12. PMID: 15499541.

Meyer H, Perrichot M, Stemmler M, Emmerich P, Schmitz H, Varaine F, Shungu R, Tshioko F, Formenty P. Outbreaks of disease suspected of being due to human monkeypox virus infection in the Democratic Republic of Congo in 2001. J Clin Microbiol. 2002 Aug;40(8):2919-21. doi: 10.1128/JCM.40.8.2919-2921.2002. PMID: 12149352; PMCID: PMC120683.

World Health Organization. Clinical management and infection prevention and control for monkeypox: Interim rapid response guidance, 10 June 2022 [Internet]. [cited 2024 Sep 28]. Available from: https://www.who.int/publications/i/item/WHO-MPX-Clinical-and-IPC-2022.1

O'Neill M, LePage T, Bester V, Yoon H, Browne F, Nemec EC. Mpox (Formally Known as Monkeypox). Physician Assist Clin. 2023 Jul;8(3):483-494. doi: 10.1016/j.cpha.2023.02.008. Epub 2023 Apr 3. PMID: 37193533; PMCID: PMC10069639.

Dusendang JR, Marwaha S, Alexeeff SE, Herrinton LJ. Presentation of rash in a community-based health system. Perm J. 2020 Nov;24:1-4. doi: 10.7812/TPP/20.035. PMID: 33482970; PMCID: PMC7849310.

Meckawy R, Stuckler D, Mehta A, Al-Ahdal T, Doebbeling BN. Effectiveness of early warning systems in the detection of infectious diseases outbreaks: a systematic review. BMC Public Health. 2022 Nov 29;22(1):2216. doi: 10.1186/s12889-022-14625-4. PMID: 36447171; PMCID: PMC9707072.

Frieden TR, Lee CT, Lamorde M, Nielsen M, McClelland A, Tangcharoensathien V. The road to achieving epidemic-ready primary health care. Lancet Public Health. 2023 May;8(5):e383-e390. doi: 10.1016/S2468-2667(23)00060-9. PMID: 37120262; PMCID: PMC10139016.

Stamenova V, Chu C, Pang A, Fang J, Shakeri A, Cram P, Bhattacharyya O, Bhatia RS, Tadrous M. Virtual care use during the COVID-19 pandemic and its impact on healthcare utilization in patients with chronic disease: A population-based repeated cross-sectional study. PLoS One. 2022 Apr 25;17(4):e0267218. doi: 10.1371/journal.pone.0267218. PMID: 35468168; PMCID: PMC9037937.

Chung-Lee L, Catallo C. A new approach to digital health? Virtual COVID-19 care: A scoping review. Digit Health. 2023 Feb 12;9:20552076231152171. doi: 10.1177/20552076231152171. PMID: 36798886; PMCID: PMC9926398.

Vandenberghe P, Ladeira LM, Gil M, Cardoso I, Rato F, Hayes JS, Connolly MA, Gala JL. Biosafety issues in patient transport during COVID-19: A case study on the Portuguese emergency services. Int J Environ Res Public Health. 2024 Jan 16;21(1):99. doi: 10.3390/ijerph21010099. PMID: 38248562; PMCID: PMC10815323.

Verreault D, Killeen SZ, Redmann RK, Roy CJ. Susceptibility of monkeypox virus aerosol suspensions in a rotating chamber. J Virol Methods. 2013;187(2):333–337.

Stone L. Mpox update for EMS personnel [Internet]. NETEC. 2024 [cited 2024 Sep 28]. Available from: https://netec.org/2024/04/12/mpox-update-for-ems-personnel/

Beeson A, Styczynski A, Hutson CL, Whitehill F, Angelo KM, Minhaj FS, Morgan C, Ciampaglio K, Reynolds MG, McCollum AM, Guagliardo SAJ. Mpox respiratory transmission: the state of the evidence. Lancet Microbe. 2023 Apr;4(4):e277-e283. doi: 10.1016/S2666-5247(23)00034-4. Epub 2023 Mar 7. PMID: 36898398; PMCID: PMC9991082.

Saro-Buendía M, Palacios-Díaz RD, Suárez-Urquiza P, Mansilla-Polo M, Bancalari-Díaz C, Cabrera-Guijo J, Armengot-Carceller M. Mpox pharyngitis. Indian J Otolaryngol Head Neck Surg. 2024 Jun;76(3):2902-2905. doi: 10.1007/s12070-024-04567-1. Epub 2024 Mar 2. PMID: 38883515; PMCID: PMC11169327.

Accordini S, Cordioli M, Pomari E, Tacconelli E, Castilletti C. People with asymptomatic or unrecognised infection potentially contribute to monkeypox virus transmission. The Lancet Microbe. 2023 Apr;4(4):e209.

Patel VM, Patel SV. Epidemiological review on monkeypox. Cureus. 2023 Feb 5;15(2):e34653. doi: 10.7759/cureus.34653. PMID: 36895541; PMCID: PMC9991112.

World Health Organization. Prevention of hospital-acquired infections: a practical guide. [Prevención de las infecciones nosocomiales: guía práctica / revisores: G Ducel, J Fabry y L Nicolle]. [Internet]. 2002 [cited 2024 Sep 28]; Available from: https://iris.who.int/handle/10665/67350

World Health Organization, Regional Office for South-East Asia. Strengthening health emergency preparedness in cities and urban settings: a framework for action for local government authorities. New Delhi (India): World Health Organization, Regional Office for South-East Asia; 2023 [cited 2023 Oct 21]. Available from: https://cdn.who.int/media/docs/default-source/searo/whe/ihm/9789290229582-2.pdf?sfvrsn=f6090736_5&download=true

Roper RL, Garzino-Demo A, Del Rio C, Bréchot C, Gallo R, Hall W, Esparza J, Reitz M, Schinazi RF, Parrington M, Tartaglia J, Koopmans M, Osorio J, Nitsche A, Huan TB, LeDuc J, Gessain A, Weaver S, Mahalingam S, Abimiku A, Vahlne A, Segales J, Wang L, Isaacs SN, Osterhaus A, Scheuermann RH, McFadden G. Monkeypox (mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies. Vaccine. 2023 May 11;41(20):3171-3177. doi: 10.1016/j.vaccine.2023.04.010. Epub 2023 Apr 21. PMID: 37088603; PMCID: PMC10120921.

de la Calle-Prieto F, Estébanez Muñoz M, Ramírez G, Díaz-Menéndez M, Velasco M, Azkune Galparsoro H, Salavert Lletí M, Mata Forte T, Blanco JL, Mora-Rillo M, Arsuaga M, de Miguel Buckley R, Arribas JR, Membrillo FJ; Working Group of the UAAN – Grupo de Estudio de Patología Importada (GEPI) and the Working Group of the Monkeypox at the SEIMC. Treat-ment and prevention of monkeypox. Enferm Infecc Microbiol Clin (Engl Ed). 2023 Dec;41(10):629-634. doi: 10.1016/j.eimce.2022.12.010. Epub 2023 Jan 7. PMID: 36624034; PMCID: PMC9823286.

Tuttle A, Hughes CM, Dvorak M, Aeschleman L, Davidson W, Wilkins K, Gigante C, Satheshkumar PS, Rao AK, Minhaj FS, Christensen BE, McQuiston JH, Hutson CL, McCollum AM. Notes from the Field: Clade II Mpox Surveillance Update - United States, October 2023-April 2024. MMWR Morb Mortal Wkly Rep. 2024 May 23;73(20):474-476. doi: 10.15585/mmwr.mm7320a4. PMID: 38781102; PMCID: PMC11115435.

Gigante CM, Korber B, Seabolt MH, Wilkins K, Davidson W, Rao AK, Zhao H, Smith TG, Hughes CM, Minhaj F, Waltenburg MA, Theiler J, Smole S, Gallagher GR, Blythe D, Myers R, Schulte J, Stringer J, Lee P, Mendoza RM, Griffin-Thomas LA, Crain J, Murray J, Atkinson A, Gonzalez AH, Nash J, Batra D, Damon I, McQuiston J, Hutson CL, McCollum AM, Li Y. Multiple lineages of monkeypox virus detected in the United States, 2021-2022. Science. 2022 Nov 4;378(6619):560-565. doi: 10.1126/science.add4153. Epub 2022 Oct 20. PMID: 36264825; PMCID: PMC10258808.

Vakaniaki EH, Kacita C, Kinganda-Lusamaki E, O'Toole Á, Wawina-Bokalanga T, Mukadi-Bamuleka D, Amuri-Aziza A, Malyamungu-Bubala N, Mweshi-Kumbana F, Mutimbwa-Mambo L, Belesi-Siangoli F, Mujula Y, Parker E, Muswamba-Kayembe PC, Nundu SS, Lushima RS, Makangara-Cigolo JC, Mulopo-Mukanya N, Pukuta-Simbu E, Akil-Bandali P, Kavunga H, Abdramane O, Brosius I, Bangwen E, Vercauteren K, Sam-Agudu NA, Mills EJ, Tshiani-Mbaya O, Hoff NA, Rimoin AW, Hensley LE, Kindrachuk J, Baxter C, de Oliveira T, Ayouba A, Peeters M, Delaporte E, Ahuka-Mundeke S, Mohr EL, Sullivan NJ, Muyembe-Tamfum JJ, Nachega JB, Rambaut A, Liesenborghs L, Mbala-Kingebeni P. Sustained human outbreak of a new MPXV clade I lineage in eastern Democratic Republic of the Congo. Nat Med. 2024 Oct;30(10):2791-2795. doi: 10.1038/s41591-024-03130-3. Epub 2024 Jun 13. PMID: 38871006; PMCID: PMC11485229.

Mitjà O, Ogoina D, Titanji BK, Galvan C, Muyembe JJ, Marks M, Orkin CM. Monkeypox. Lancet. 2023 Jan 7;401(10370):60-74. doi: 10.1016/S0140-6736(22)02075-X. Epub 2022 Nov 17. Erratum in: Lancet. 2022 Dec 3;400(10367):1926. doi: 10.1016/S0140-6736(22)02414-X. PMID: 36403582; PMCID: PMC9671644.

Saudi Center for Disease Prevention and Control. Monkeypox guidelines. Riyadh (Saudi Arabia): Saudi Center for Disease Prevention and Control; 2023 Jun 1 [cited 2023 Oct 21]. Available from: https://covid19.cdc.gov.sa/wp-content/uploads/2023/06/Monkeypox-Guidelines-01-June-2023-V1.4.pdf

European Centre for Disease Prevention and Control. Monkeypox infection prevention and control guidance for primary and acute care settings. 16 August 2022. ECDC: Stockholm; 2022. https://www.ecdc.europa.eu/sites/default/files/documents/Monkeypox-infection-prevention-and-control-guidance.pdf

Björk J, Bonander C, Moghaddassi M, Rasmussen M, Malmqvist U, Kahn F, Inghammar M. Surveillance of COVID-19 vaccine effectiveness - a real-time case-control study in southern Sweden. Epidemiol Infect. 2022 Mar 2;150:1-15. doi: 10.1017/S0950268822000425. Epub ahead of print. PMID: 35232506; PMCID: PMC8924553.

Centers for Disease Control. Interim Clinical Guidance for the Treatment of Monkeypox: Medical Countermeasures Available for the Treatment of Monkeypox. Centers for Disease Control and Prevention. Updated 2022 June 17. 2022. https://www.cdc.gov/poxvirus/monkeypox/treatment.html Accessed 2024 August 29.

Fox T, Gould S, Princy N, Rowland T, Lutje V, Kuehn R. Therapeutics for treating mpox in humans. Cochrane Database of Systematic Reviews 2023, Issue 3. Art. No.: CD015769. doi: 10.1002/14651858.CD015769

Vigne S, Duraffour S, Andrei G, Snoeck R, Garin D, Crance JM. Inhibition of vaccinia virus replication by two small interfering RNAs targeting B1R and G7L genes and their synergistic combination with cidofovir. Antimicrob Agents Chemother. 2009;53(6):2579-2588. doi:10.1128/AAC.01626-08

Grosenbach DW, Honeychurch K, Rose EA, Chinsangaram J, Frimm A, Maiti B, Lovejoy C, Meara I, Long P, Hruby DE. Oral Tecovirimat for the Treatment of Smallpox. N Engl J Med. 2018 Jul 5;379(1):44-53. doi: 10.1056/NEJMoa1705688. PMID: 29972742; PMCID: PMC6086581.

Downloads

Published

2024-12-06

How to Cite

Aloqaily, H., Abdurhman Alnafea, R. ., Abdullah Alotaibi , S. ., Bakir, M., Bin Nafisah, S., & Mzahim, B. (2024). Mpox Preparedness and Response 2024: Position Statement of The Disaster Management Experts Club. The Journal of Medicine, Law & Public Health, 5(1), 514–526. https://doi.org/10.52609/jmlph.v5i1.163

Issue

Section

Reviews

Most read articles by the same author(s)

1 2 3 > >>